Clagett-Dame M - Search Results

1

Inhibition of mammary tumor growth by a novel nontoxic retinoid: chemotherapeutic evaluation of a C-linked analog of 4-HPR-glucuronide.

Alshafie GA, Walker JR, Curley RW Jr, Clagett-Dame M, Highland MA, Nieves NJ, Stonerock LA, Abou-Issa H. Alshafie GA, et al. Anticancer Res. 2005 May-Jun;25(3c):2391-8. Anticancer Res. 2005. PMID: 16082771 Free article.

2

4-HPR Is an Endoplasmic Reticulum Stress Aggravator and Sensitizes Breast Cancer Cells Resistant to TRAIL/Apo2L.

Anding AL, Jones JD, Newton MA, Curley RW Jr, Clagett-Dame M. Anding AL, et al. Among authors: clagett dame m. Anticancer Res. 2018 Aug;38(8):4403-4416. doi: 10.21873/anticanres.12742. Anticancer Res. 2018. PMID: 30061204

3

Synthesis and preliminary chemotherapeutic evaluation of the fully C-linked glucuronide of N-(4-hydroxyphenyl)retinamide.

Walker JR, Alshafie G, Nieves N, Ahrens J, Clagett-Dame M, Abou-Issa H, Curley RW Jr. Walker JR, et al. Bioorg Med Chem. 2006 May 1;14(9):3038-48. doi: 10.1016/j.bmc.2005.12.044. Epub 2006 Jan 10. Bioorg Med Chem. 2006. PMID: 16412653 Free PMC article.

4

Solid phase-assisted synthesis and screening of a small library of N-(4-hydroxyphenyl)retinamide (4-HPR) analogs.

Mershon SM, Anding AL, Chapman JS, Clagett-Dame M, Stonerock LA, Curley RW Jr. Mershon SM, et al. Bioorg Med Chem Lett. 2007 Feb 1;17(3):836-40. doi: 10.1016/j.bmcl.2006.10.050. Epub 2006 Oct 25. Bioorg Med Chem Lett. 2007. PMID: 17112722 Free PMC article.

5

Chemopreventive activities of C-glucuronide/glycoside analogs of retinoid-O-glucuronides against breast cancer development and growth.

Curley RW Jr, Abou-Issa H, Panigot MJ, Repa JJ, Clagett-Dame M, Alshafie G. Curley RW Jr, et al. Anticancer Res. 1996 Mar-Apr;16(2):757-63. Anticancer Res. 1996. PMID: 8687125

6

Chemopreventive activity of a C-glucuronide analog of N-(4-hydroxyphenyl) retinamide-O-glucuronide against mammary tumor development and growth.

Abou-Issa HM, Alshafie GA, Curley RW Jr, Wong MF, Clagett-Dame M, Repa JJ, Sikri V. Abou-Issa HM, et al. Anticancer Res. 1999 Mar-Apr;19(2A):999-1004. Anticancer Res. 1999. PMID: 10368645

7

Chemotherapeutic evaluation of 4-hydroxybenzylretinone (4-HBR), a nonhydrolyzable C-linked analog of N-(4-hydroxyphenyl) retinamide (4-HPR) against mammary carcinogenesis.

Abou-Issa H, Curley RW Jr, Alshafie GA, Weiss KL, Clagett-Dame M, Chapman JS, Mershon SM. Abou-Issa H, et al. Anticancer Res. 2001 Nov-Dec;21(6A):3839-44. Anticancer Res. 2001. PMID: 11911255

8

Improved Synthesis of the C-Glucuronide/Glycoside of 4-Hydroxybenzylretinone (4-HBR).

Cavanaugh KR, Narayanasamy S, Walker JR, Clagett-Dame M, Curley RW Jr. Cavanaugh KR, et al. Among authors: clagett dame m. J Carbohydr Chem. 2016;35(5):249-260. doi: 10.1080/07328303.2016.1227831. Epub 2016 Oct 13. J Carbohydr Chem. 2016. PMID: 28626297 Free PMC article.

9

Hydrolysis of 4-HPR to atRA occurs in vivo but is not required for retinamide-induced apoptosis.

Chapman JS, Weiss KL, Curley RW Jr, Highland MA, Clagett-Dame M. Chapman JS, et al. Arch Biochem Biophys. 2003 Nov 15;419(2):234-43. doi: 10.1016/j.abb.2003.09.001. Arch Biochem Biophys. 2003. PMID: 14592467

10

An unhydrolyzable analogue of N-(4-hydroxyphenyl)retinamide. synthesis and preliminary biological studies.

Weiss KL, Alshafie G, Chapman JS, Mershon SM, Abou-Issa H, Clagett-Dame M, Curley RW Jr. Weiss KL, et al. Bioorg Med Chem Lett. 2001 Jun 18;11(12):1583-6. doi: 10.1016/s0960-894x(01)00230-x. Bioorg Med Chem Lett. 2001. PMID: 11412986

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters